MALIGNANT ANGIOENDOTHELIOMATOSIS PROLIFERANS TREATED WITH DOXORUBICINKEAHEY TM; GUERRY D IV; TUTHILL RJ et al.1982; ARCH. DERMATOL. (CHIC., 1960); ISSN 0003-987X; USA; DA. 1982; VOL. 118; NO 7; PP. 512-514; BIBL. 16 REF.Article

COMPARISON OF AGENTS PRODUCING A NEUTROPHILIC LEUKOCYTOXIS IN MAN. HYDROCORTISONE, PREDNISONE, ENDOTOXIN, AND ETIOCHOLANOLONE. = COMPARAISON D'AGENTS RESPONSABLES DE LEUCOCYTOSE NEUTROPHILE CHEZ L'HOMME: HYDROCORTISONE, PREDNISONE, ENDOTOXINE ET ETIOCHOLANOLONEDALE DC; FAUCI AS; GUERRY D IV et al.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 56; NO 4; PP. 808-813; BIBL. 29 REF.Article

BLYMPHOCYTE EXPRESSION OF A RECOGNITION LOCUS FOR HUMAN MONOCYTES AND MACROPHAGESGUERRY D IV; DUSAK BA; SCHREIBER AD et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 6; PP. 2446-2452; BIBL. 58 REF.Article

EFFECT OF CYTOCHALASIN B ON HUMAN MONOCYTE BINDING AND SPHERING OF IGG-COATED HUMAN ERYTHROCYTES.HERSKOVITZ B; GUERRY D IV; COOPER RA et al.1977; BLOOD; U.S.A.; DA. 1977; VOL. 49; NO 2; PP. 289-294; BIBL. 1 P.Article

GRANULOCYTE-ASSOCIATED IGG IN NEUTROPENIC DISORDERSCINES DB; PASSERO F; GUERRY D IV et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 1; PP. 124-132; BIBL. 36 REF.Article

Gene therapy for melanoma in humansGUTZMER, R; GUERRY, D. IV.Hematology/oncology clinics of North America. 1998, Vol 12, Num 3, issn 0889-8588, viii,519-538 [21 p.]Article

Disseminated melanoma : is there as new standard therapy ?GUERRY, D. IV; SCHUCHTER, L. M.The New England journal of medicine. 1992, Vol 327, Num 8, pp 560-561, issn 0028-4793Article

TOPICAL CHEMOTHERAPY OF DYSPLASTIC MELANOCYTIC NEVI WITH 5% FLUOROURACILBONDI EE; CLARK WH JR; ELDER D et al.1981; ARCH. DERMATOL. (CHIC., 1960); ISSN 0003-987X; USA; DA. 1981; VOL. 117; NO 2; PP. 89-92; BIBL. 13 REF.Article

Lessons from tumor progression : the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolentGUERRY, D. IV; SYNNESTVEDT, M; ELDER, D. E et al.Journal of investigative dermatology. 1993, Vol 100, Num 3, pp 342S-345S, issn 0022-202XArticle

Interferon-γ regulates the T cell response to precursor nevi and biologically early melanomaGUERRY, D. IV; ALEXANDER, M. A; ELDER, D. E et al.The Journal of immunology (1950). 1987, Vol 139, Num 1, pp 305-312, issn 0022-1767Article

Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemiaHERLYN, M; LANGE, B; BENNICELLI, J et al.Leukemia research. 1984, Vol 8, Num 3, pp 323-334, issn 0145-2126Article

Skin markings in malignant melanomaBONDI, E. E; ELDER, D. E; GUERRY, D. IV et al.JAMA, the journal of the American Medical Association. 1983, Vol 250, Num 4, pp 503-505, issn 0098-7484Article

Characterization of tenascin secreted by human melanoma cellsHERLYN, M; GRAEVEN, U; SPEICHER, D et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4853-4858, issn 0008-5472Conference Paper

Clinically recognized dysplastic nevi : A central risk factor for cutaneous melanomaTUCKER, M. A; HALPERN, A; HOLLY, E. A et al.JAMA, the journal of the American Medical Association. 1997, Vol 277, Num 18, pp 1439-1444, issn 0098-7484Article

The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)ELDER, D. E; GUERRY, D. IV; VANHORN, M et al.Cancer. 1985, Vol 56, Num 2, pp 413-418, issn 0008-543XArticle

Primary melanoma cells of the vertical growth phase: similarities to metastatic cellsHERLYN, M; BALABAN, G; CLARK, W. H et al.Journal of the National Cancer Institute. 1985, Vol 74, Num 2, pp 283-289, issn 0027-8874Article

HLA-DR histocompatibility leukocyte antiges permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytesGUERRY, D. IV; ALEXANDER, M. A; HERLYN, M. F. H et al.The Journal of clinical investigation. 1984, Vol 73, Num 1, pp 267-271, issn 0021-9738Article

Acquired precursors of cutaneous malignant melanoma: the familial dysplastic nevus syndromeGREENE, M. H; CLARK, W. H. JR; TUCKER, M. A et al.The New England journal of medicine. 1985, Vol 312, Num 2, pp 91-97, issn 0028-4793Article